Eight ways 340B covered entities can maximize cash flow and savings during the COVID-19 public health emergency
The impact of COVID-19 on hospital and clinic finances has been fierce and immediate, making the 340B program more important than ever to covered entities struggling to remain in the black while experiencing reduced revenue from elective procedures. Over the last few weeks, PSG has assembled a team of financial, operational and pharmacy experts to identify best practices our clients can use to optimize their 340B program for immediate operational efficiencies, cash flow enhancement and savings.
